title: Insulin glargine use and short-term incidence of breast cancer - a four-year population-based observation.
authors.forename: Rickard
authors.initials: R
authors.lastname: Ljung
authors.forename: Mats
authors.initials: M
authors.lastname: Talbäck
authors.forename: Bengt
authors.initials: B
authors.lastname: Haglund
authors.forename: Junmei Miao
authors.initials: JM
authors.lastname: Jonasson
authors.forename: Soffia
authors.initials: S
authors.lastname: Gudbjörnsdòttir
authors.forename: Gunnar
authors.initials: G
authors.lastname: Steineck
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000139:chemically induced* / Q000453:epidemiology* / Q000209:etiology; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D015994:Incidence; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting / Q000009:adverse effects*; D008875:Middle Aged; D011379:Prognosis; D012307:Risk Factors; D013548:Sweden / Q000453:epidemiology; D013997:Time Factors
chemical_list: D007004:Hypoglycemic Agents; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine